Benzodiazepines

Benzodiazepines are among the most widely prescribed drug classes in the United States, valued for anxiolytic (anxiety-reducing), hypnotic (sleep-inducing), anticonvulsant, and muscle-relaxant effects. They share a common mechanism but differ in potency, onset, and how long they act, which is why some are used for acute panic and others for sustained sedation or seizure control. Individual agents — alprazolam, clonazepam, diazepam, lorazepam, and others — are documented on their own pages in this library; this page describes the class as a whole and the risks that apply across it.

Benzodiazepines work by raising the activity of gamma-aminobutyric acid (GABA), the brain's principal inhibitory neurotransmitter. They act as positive allosteric modulators at the GABA-A receptor, meaning they do not activate the receptor themselves but amplify GABA's own calming signal, reducing the excitability of neurons throughout the central nervous system. This produces sedation, reduced anxiety, muscle relaxation, and a higher seizure threshold. With sustained use the brain adapts — GABA-A receptors downregulate and excitatory glutamate systems compensate — which underlies both tolerance (needing more for the same effect) and the withdrawal syndrome that appears when the drug is stopped.

Short-term effects include drowsiness, reduced anxiety, muscle relaxation, slowed reaction time, impaired coordination, and memory problems, particularly for events during intoxication. Higher doses deepen sedation and can cause confusion and slurred speech. Used alone by mouth, benzodiazepines have a relatively low risk of fatal acute toxicity in healthy adults — but this changes dramatically when they are combined with other depressants, and it does not make regular use safe, because the main dangers of this class emerge over time through tolerance and dependence.

The central risk of benzodiazepines is dependence and withdrawal. Regular use — even at prescribed doses for as little as a few weeks — can produce physical dependence, and stopping abruptly can trigger a withdrawal syndrome that includes anxiety, tremor, insomnia, agitation, and, because these drugs slow brain activity, a rebound effect that can cause seizures. Benzodiazepine withdrawal is problematic and occasionally dangerous but is rarely life-threatening on its own (unlike barbiturate withdrawal, which more often is); even so, it should never be stopped suddenly. Discontinuation is done by slow tapering over weeks to months under medical supervision. The second major danger is combination with other central-nervous-system depressants. Taking benzodiazepines with opioids, alcohol, or other sedatives sharply raises the risk of profound sedation, suppressed breathing, and fatal overdose — nearly 14% of U.S. opioid-overdose deaths in 2021 also involved a benzodiazepine, and both drug classes carry the FDA's most stringent 'boxed' warning about using them together. Long-term use is also associated with tolerance, cognitive impairment, and falls, particularly in older adults.

sedation, anxiolysis; euphoria (esp. rapid-onset, when misused)

classed by action — <6 hr to >24 hr; some have active metabolites

loss of motor coordination, respiratory depression, memory loss/blackouts, amnesia, slurred speech, delirium; tolerance + dependence; withdrawal incl. seizures (flumazenil reverses)

FDA-approved for insomnia, anxiety, panic, muscle spasm, seizures, alcohol withdrawal, anesthesia adjunct

alprazolam ~29.9M Rx (2025); NFLIS alprazolam total 699,719 since 1997